Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 31 Records) |
| Query Trace: Leukemia and CYP3A4[original query] |
|---|
| Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies. Pharmacogenetics 2002 Nov 12 (8): 605-11. Blanco Javier G, Edick Mathew J, Hancock Michael L, Winick Naomi J, Dervieux Thierry, Amylon Michael D, Bash Robert O, Behm Frederick G, Camitta Bruce M, Pui Ching-Hon, Raimondi Susana C, Relling Mary |
| Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia. Blood 2004 Jan 103 (1): 67-72. Kishi Shinji, Yang Wenjian, Boureau Benoit, Morand Stanislas, Das Soma, Chen Peixian, Cook Edwin H, Rosner Gary L, Schuetz Erin, Pui Ching-Hon, Relling Mary |
| Polymorphisms in genes involved in the corticosteroid response and the outcome of childhood acute lymphoblastic leukemia. American journal of pharmacogenomics : genomics-related research in drug development and clinical practice 2004 4 (5): 331-41. Fleury Isabelle, Primeau Melanie, Doreau Agnes, Costea Irina, Moghrabi Albert, Sinnett Daniel, Krajinovic Ma |
| Association of CYP3A4 genotype with detection of Vgamma/Jbeta trans-rearrangements in the peripheral blood leukocytes of pediatric cancer patients undergoing chemotherapy for ALL. Leukemia research 2004 Dec 28 (12): 1281-6. Lopes Luiz Fernando, Piccoli Fábio De Simone, Paixão Valéria A, Latorre Maria do Rosário D O, Camargo Beatriz de, Simpson Andrew J G, Caballero Otávia |
| The GST deletions and NQO1*2 polymorphism confers interindividual variability of response to treatment in patients with acute myeloid leukemia. Leukemia research 2007 Jul 31 (7): 947-53. Barragan Eva, Collado Maria, Cervera Jose, Martin Guillermo, Bolufer Pascual, Roman Jose, Sanz Miguel |
| Genetic predictors of glucocorticoid-induced hypertension in children with acute lymphoblastic leukemia. Pharmacogenetics and genomics 2008 Jun 18 (6): 507-14. Kamdem Landry K, Hamilton Leo, Cheng Cheng, Liu Wei, Yang Wenjian, Johnson Julie A, Pui Ching-Hon, Relling Mary |
| TotalPlex gene amplification using bulging primers for pharmacogenetic analysis of acute lymphoblastic leukemia. Molecular and cellular probes 2008 Jun 22 (3): 193-200. Kang Hyoung Jin, Oh Yongtaek, Chun Sung-Min, Seo Young Jin, Shin Hee Young, Kim Chul Woo, Ahn Hyo Seop, Han Byoung-D |
| Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes. Neurology 2011 Mar 76 (12): 1059-65. Hasan S K, Buttari F, Ottone T, Voso M T, Hohaus S, Marasco E, Mantovani V, Garagnani P, Sanz M A, Cicconi L, Bernardi G, Centonze D, Lo-Coco |
| Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia. Pediatric blood & cancer 2011 Mar 56 (3): 361-7. Egbelakin Akinbode, Ferguson Michael J, MacGill Emily A, Lehmann Amalia S, Topletz Ariel R, Quinney Sara K, Li Lang, McCammack Kevin C, Hall Stephen D, Renbarger Jamie |
| Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapy. Haematologica 2013 Feb 98 (2): 193-200. Angelini Sabrina, Soverini Simona, Ravegnini Gloria, Barnett Matt, Turrini Eleonora, Thornquist Mark, Pane Fabrizio, Hughes Timothy P, White Deborah L, Radich Jerald, Kim Dong Wook, Saglio Giuseppe, Cilloni Daniela, Iacobucci Ilaria, Perini Giovanni, Woodman Richard, Cantelli-Forti Giorgio, Baccarani Michele, Hrelia Patrizia, Martinelli Giovan |
| Influence of enzyme and transporter polymorphisms on trough imatinib concentration and clinical response in chronic myeloid leukemia patients. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013 Mar 24 (3): 756-60. Seong S J, Lim M, Sohn S K, Moon J H, Oh S-J, Kim B S, Ryoo H M, Chung J S, Joo Y D, Bang S M, Jung C W, Kim D H, Park S Y, Yoon S S, Kim I, Lee H G, Won J H, Min Y H, Cheong J W, Park J S, Eom K S, Hyun M S, Kim M K, Kim H, Park M R, Park J, Kim C S, Kim H J, Kim Y K, Park E K, Zang D Y, Jo D Y, Lee H W, Yoon Y |
| CYP3A4*1B polymorphism and cancer risk: a HuGE review and meta-analysis. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2012 Nov . Zhou LP, Yao F, Luan H, Wang YL, Dong XH, Zhou WW, Wang QH |
| Pharmacogenetic analysis of pediatric patients with acute lymphoblastic leukemia: a possible association between survival rate and ITPA polymorphism. PloS one 2012 7 (9): 9. Kim H, Kang HJ, Kim HJ, Jang MK, Kim NH, Oh Y, Han BD, Choi JY, Kim CW, Lee JW, Park KD, Shin HY, Ahn HS |
| The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes. Leukemia & lymphoma 2014 Jul 55 (7): 1538-43. Fabiani Emiliano, Fianchi Luana, Falconi Giulia, Boncompagni Riccardo, Criscuolo Marianna, Guidi Francesco, La Brocca Antonella, Hohaus Stefan, Leone Giuseppe, Voso Maria Tere |
| In interaction with gender a common CYP3A4 polymorphism may influence the survival rate of chemotherapy for childhood acute lymphoblastic leukemia. The pharmacogenomics journal 2015 Jun 15 (3): 241-7. Gézsi A, Lautner-Csorba O, Erdélyi D J, Hullám G, Antal P, Semsei Á F, Kutszegi N, Hegyi M, Csordás K, Kovács G, Szalai |
| Genetic variations of hOCT1 gene and CYP3A4/A5 genes and their association with imatinib response in Chronic Myeloid Leukemia. European journal of pharmacology 2015 Aug 765 124-130. Vaidya Shantashri, Ghosh Kanjaksha, Shanmukhaiah Chandrakala, Vundinti Babu R |
| Polymorphisms in CYP1B1, CYP3A5, GSTT1, and SULT1A1 Are Associated with Early Age Acute Leukemia. PloS one 2015 10 (5): e0127308. Lopes Bruno Almeida, Emerenciano Mariana, Gonçalves Bruno Alves Aguiar, Vieira Tállita Meciany, Rossini Ana, Pombo-de-Oliveira Maria |
| Frequency and prognostic significant of CYP3A4-A-290G polymorphism in acute myeloid leukemia. Journal of advanced research 2014 Nov 5 (6): 657-61. Ali Gamal T, Al-Azhary Nevin M, Mokhtar Doha |
| Association of CYP3A5 Expression and Vincristine Neurotoxicity in Pediatric Malignancies in Turkish Population. Journal of pediatric hematology/oncology 2017 Jul . Kayilio?lu Hülya, Kocak Ulker, Kan Karaer Derya, Percin Emriye F, Sal Ertan, Tekkesin Funda, Isik Melek, Oner Nergiz, Belen Fatma B, Yilmaz Keskin Ebru, Okur Arzu, Albayrak Meryem, Kaya Zuhre, Pinarli Faruk G, Yenicesu Idil, Karadeniz Ceyda, Oguz Aynur, Gursel Turk |
| Influence of CYP2C8 polymorphisms on imatinib steady-state trough level in chronic myeloid leukemia and gastrointestinal stromal tumor patients. Pharmacogenetics and genomics 2017 06 27 (6): 223-226. Verboom Michiel C, Visser Loes, Kouwen Sander, Swen Jesse J, Diepstraten Jeroen, Posthuma Ward F, Gelderblom Hans, van Lammeren Daniëlle, Wilms Erik |
| CYP3A4*1B Polymorphism and Cancer Risk: A Meta-Analysis Based on 55 Case-control Studies. Annals of clinical and laboratory science 2018 Jul 48 (4): 538-545. Zheng Yuan, Xu Yi, Zhou Bu-Yu, Sun Liang, Yu Peng-Bo, Zhang Lei, Xu Jing, Wang Jing-J |
| Effects of polymorphisms in NR1I2, CYP3A4, and ABC transporters on the steady-state plasma trough concentrations of bosutinib in Japanese patient with chronic myeloid leukemia. Medical oncology (Northwood, London, England) 2018 May 35 (6): 90. Abumiya Maiko, Mita Akiko, Takahashi Saori, Yoshioka Tomoko, Kameoka Yoshihiro, Takahashi Naoto, Miura Masato |
| The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients. Archives of medical science : AMS 2018 Oct 14 (6): 1416-1423. Belohlavkova Petra, Vrbacky Filip, Voglova Jaroslava, Racil Zdenek, Zackova Daniela, Hrochova Katerina, Malakova Jana, Mayer Jiri, Zak Pav |
| An LC-MS/MS Bioanalytical Assay for the Determination of Gilteritinib in Rat Plasma and Application to a Drug-Drug Interaction Study. Drug design, development and therapy 2020 6 14 2061-2067. Wang Qiong, Chen Zhe, Chen Dingwen, Ye Xia-Y |
| Factors affecting high-grade hepatotoxicity of tyrosine kinase inhibitors in cancer patients: a multi-center observational study. European journal of clinical pharmacology 2020 May . Han Ji Min, Han Hye Won, Yee Jeong, Kim Min Kyoung, Moon Jin Young, Cho Soyeon, Jung Dasom, Cho Yoon Sook, Seo Inyoung, Kim Jae Youn, Gwak Hye S |
| Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor. Clinical pharmacokinetics 2020 4 59 (10): 1273-1290. James Angela Joubert, Smith Catherine C, Litzow Mark, Perl Alexander E, Altman Jessica K, Shepard Dale, Kadokura Takeshi, Souda Kinya, Patton Melanie, Lu Zheng, Liu Chaofeng, Moy Selina, Levis Mark J, Bahceci Erk |
| Phase 2 study of the safety and efficacy of umbralisib in patients with CLL who are intolerant to BTK or PI3K? inhibitor therapy. Blood 2020 12 137 (20): 2817-2826. Mato Anthony R, Ghosh Nilanjan, Schuster Stephen J, Lamanna Nicole, Pagel John M, Flinn Ian W, Barrientos Jacqueline C, Rai Kanti R, Reeves James A, Cheson Bruce D, Barr Paul M, Kambhampati Suman, Lansigan Frederick, Pu Jeffrey J, Skarbnik Alan P, Roeker Lindsey, Fonseca Gustavo A, Sitlinger Andrea, Hamadeh Issam S, Dorsey Colleen, LaRatta Nicole, Weissbrot Hanna, Luning Prak Eline T, Tsao Patricia, Paskalis Dana, Sportelli Peter, Miskin Hari P, Weiss Michael S, Svoboda Jakub, Brander Danielle |
| Pharmacogenetics-Based Preliminary Algorithm to Predict the Incidence of Infection in Patients Receiving Cytotoxic Chemotherapy for Hematological Malignancies: A Discovery Cohort. Frontiers in pharmacology 2021 3 12 602676. Martinez Matias F, Alveal Enzo, Soto Tomas G, Bustamante Eva I, Ávila Fernanda, Bangdiwala Shrikant I, Flores Ivonne, Monterrosa Claudia, Morales Ricardo, Varela Nelson M, Fohner Alison E, Quiñones Luis |
| Development of Physiology Based Pharmacokinetic Model to Predict the Drug Interactions of Voriconazole and Venetoclax. Pharmaceutical research 2022 Jun . Dong Ji, Liu Shuai-Bing, Rasheduzzaman Jony Md, Huang Chen-Rong, Miao Li-Y |
| Population pharmacokinetics and pharmacogenetics analyses of imatinib in Chinese patients with chronic myeloid leukemia in a real-world situation. Cancer chemotherapy and pharmacology 2023 8 . Shiyu He, Qianhang Shao, Jinxia Zhao, Jialu Bian, Yinyu Zhao, Xu Hao, Yuanyuan Li, Lei Hu, Boyu Liu, Huan He, Lin Huang, Qian Jia |
- Page last reviewed:Feb 1, 2024
- Content source: